Back to Search
Start Over
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.
- Source :
-
Journal of Infectious Diseases . Feb2022, Vol. 225 Issue 3, p436-442. 7p. - Publication Year :
- 2022
-
Abstract
- <bold>Background: </bold>Detailed cytomegalovirus (CMV) kinetics in donor CMV-seropositive, recipient CMV-seronegative (D+/R-) transplant recipients receiving preemptive therapy (PET) have not been fully defined.<bold>Methods: </bold>The study population consisted of the PET arm of a randomized CMV prevention trial in D+/R- liver transplant recipients. CMV DNA polymerase chain reaction (PCR) assays were performed weekly for 100 days using a sensitive assay. Viral load and clinical parameters were compared for patients with or without high-level increase (defined as higher than the group median log10 increase in viral load from baseline after PET initiation).<bold>Results: </bold>Among 79 patients, 93.6% (74/79) developed an increase from baseline viral loads of median 120 IU/mL to 3350 IU/mL; 25.7% (19/74) of the patients had peak levels >10 000 IU/mL. None of the patients with rise in viral load underwent testing for CMV resistance, and viremia resolved with PET with valganciclovir. Patients with high-level increase in viral load had a significantly lower rate of recurrent viremia than those without such increase (16/40 [40%] vs 28/39 [71.8%], respectively; P = .004).<bold>Conclusions: </bold>A majority of D+/R- recipients had a marked increase in viral load after initiation of PET before resolution of viremia. This phenomenon is associated with lower rates of subsequent recurrent viremia and does not necessarily imply antiviral resistance. [ABSTRACT FROM AUTHOR]
- Subjects :
- *LIVER transplantation
*VIRAL load
*CYTOMEGALOVIRUSES
*DNA polymerases
*POLYMERASE chain reaction
*CYTOMEGALOVIRUS disease prevention
*GANCICLOVIR
*CYTOMEGALOVIRUS diseases
*PATIENTS
*ANTIVIRAL agents
*DYNAMICS
*RANDOMIZED controlled trials
*VIREMIA
*RESEARCH funding
*STATISTICAL sampling
*TRANSPLANTATION of organs, tissues, etc.
Subjects
Details
- Language :
- English
- ISSN :
- 00221899
- Volume :
- 225
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Journal of Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 155028351
- Full Text :
- https://doi.org/10.1093/infdis/jiab132